Clinical Trial Update: to Assess the Eradication Rate of 14-day Bismuth/Amoxicillin/PCAB Triple Therapy for the Treatment of Helicobacter Pylori Infection [NA]

View source ↗

Summary

The document reports an ongoing clinical trial evaluating a 14-day triple therapy consisting of bismuth, amoxicillin, and a potassium-competitive acid blocker f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• AMOXICILLIN (AMOXICILLIN)
• Bismuth subsalicylate (bismuth subsalicylate)
• Vonoprazan (vonoprazan)

Snippet

Sponsor: Kaohsiung Medical University | Conditions: HELICOBACTER PYLORI INFECTIONS | NA | Status: ENROLLING_BY_INVITATION